Canada - English - Health Canada

teva canada limited - cefazolin (cefazolin sodium) - powder for solution - 1g - cefazolin (cefazolin sodium) 1g - first generation cephalosporins

Canada - English - Health Canada

teva canada limited - cefazolin (cefazolin sodium) - powder for solution - 10g - cefazolin (cefazolin sodium) 10g - first generation cephalosporins

Canada - English - Health Canada

sterimax inc - cefazolin (cefazolin sodium) - powder for solution - 1g - cefazolin (cefazolin sodium) 1g - first generation cephalosporins

Canada - English - Health Canada

sterimax inc - cefazolin (cefazolin sodium) - powder for solution - 10g - cefazolin (cefazolin sodium) 10g - first generation cephalosporins

Canada - English - Health Canada

hikma canada limited - cefazolin (cefazolin sodium) - powder for solution - 500mg - cefazolin (cefazolin sodium) 500mg - first generation cephalosporins

Canada - English - Health Canada

hikma canada limited - cefazolin (cefazolin sodium) - powder for solution - 1g - cefazolin (cefazolin sodium) 1g - first generation cephalosporins

Canada - English - Health Canada

hikma canada limited - cefazolin (cefazolin sodium) - powder for solution - 10g - cefazolin (cefazolin sodium) 10g - first generation cephalosporins

United States - English - NLM (National Library of Medicine)

cardinal health - cefazolin sodium (unii: p380m0454z) (cefazolin - unii:ihs69l0y4t) - to reduce the development of drug-resistant bacteria and maintain the effectiveness of cefazolin for injection, usp and other antibacterial drugs, cefazolin for injection, usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. cefazolin for injection, usp is indicated for the treatment of the following serious infections due to susceptible organisms. respiratory tract infections due to s. pneumoniae , klebsiella species, h. influenzae , s. aureus (penicillin-sensitive and penicillin-resistant), and group a beta-hemolytic streptococci. injectable benzathine penicillin is considered to be the drug of choice in treatment and prevention of streptococcal infections, including the

United States - English - NLM (National Library of Medicine)

medical purchasing solutions, llc - cefazolin sodium (unii: p380m0454z) (cefazolin - unii:ihs69l0y4t) - to reduce the development of drug-resistant bacteria and maintain the effectiveness of cefazolin for injection, usp and other antibacterial drugs, cefazolin for injection, usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. cefazolin for injection, usp is indicated for the treatment of the following serious infections due to susceptible organisms. respiratory tract infections due to streptococcus pneumoniae , klebsiella species, h. influenzae , staphylococcus aureus (penicillin-sensitive and penicillin-resistant), and group a beta-hemolytic streptococci. injectable benzathine penicillin is considered to be the dru

United States - English - NLM (National Library of Medicine)

sandoz inc - cefazolin sodium (unii: p380m0454z) (cefazolin - unii:ihs69l0y4t) - cefazolin for injection, usp is indicated in the treatment of the following infections due to susceptible organisms: respiratory tract infections: due to s. pneumoniae, klebsiella species, h. influenzae, s. aureus (penicillin-sensitive and penicillin-resistant), and group a beta-hemolytic streptococci. injectable benzathine penicillin is considered to be the drug of choice in treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. cefazolin for injection, usp is effective in the eradication of streptococci from the nasopharynx; however, data establishing the efficacy of cefazolin for injection, usp in the subsequent prevention of rheumatic fever are not available at present. urinary tract infections: due to e. coli, p. mirabilis, klebsiella species, and some strains of enterobacter and enterococci. skin and skin structure infections: due to s. aureus (penicillin-sensitive and penicillin-resistant), group a beta-hemolytic streptococci, and other strains of str